Search Results
64 results
Your search is now limited to «Leukemia» expert search.
Your search is now limited to only one Source. To return to results from all sources click here. 02/15/2019 11:27
Conditions : Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts-2 Interventions : Drug: AG-120; Drug: Placebo for AG-120; Drug: AG-221; Drug: Placebo for AG-221 Sponsors : Stichting Hemato-Oncologie voor Volwassenen Nederland; Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG) Not yet recruiting. 02/15/2019 11:27
Supportive care including blood product transfusions, antiemetic medications, antiviral and antifungal medications, growth factor support, tumor lysis syndrome prophylaxis, or empiric antibiotics may be used at the clinical discretion of the provider. 02/08/2019 09:17
Conditions : Blasts 5 Percent or More of Bone Marrow Nucleated Cells; Central Nervous System Neoplasm; ETV6 Gene Rearrangement; Infantile Fibrosarcoma; NTRK1 Fusion Positive; NTRK1 Gene Rearrangement; NTRK2 Fusion Positive; NTRK2 Gene Rearrangement; NTRK3 Fusion Positive; NTRK3 Gene Rearrangement; Recurrent Acute Leukemia; Refractory Acute Leukemia; Solid Neoplasm Intervention : Drug: Larotrectinib Sponsors : Children's Oncology Group; National Cancer Institute (NCI) Not yet recruiting. 02/06/2019 10:19
Condition : Chronic Myeloid Leukemia Interventions : Drug: Bosutinib; Drug: Ropeginterferon Sponsors : St. Olavs Hospital; Haukeland University Hospital; Oslo University Hospital; University Hospital of North Norway; Helse Stavanger HF; Henri Mondor University Hospital; Hôpital René Huguenin; Hôpital Mignot, Versailles Paris; Uppsala University Hospital; Odense University Hospital Not yet recruiting. 01/31/2019 10:51
Conditions : Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Leukemia (SLL) Interventions : Drug: Zanubrutinib; Drug: Obinutuzumab; Drug: Venetoclax Sponsors : Memorial Sloan Kettering Cancer Center; BeiGene USA, Inc.; Roche-Genentech; Massachusetts General Hospital Not yet recruiting. 01/31/2019 10:49
Conditions : Blasts 5 Percent or More of Bone Marrow Nucleated Cells; IDH2 Gene Mutation; Recurrent Acute Myeloid Leukemia Interventions : Drug: Enasidenib Mesylate; Drug: Liposome-encapsulated Daunorubicin-Cytarabine Sponsors : Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI) Not yet recruiting. 01/30/2019 07:39
The current national acute lymphoblastic leukaemia (ALL) trial in adults investigated whether a low (reduced) intensity chemotherapy regimen prior to transplant could improve the outcome of patients with ALL who are over 40 years of age. 01/23/2019 08:47
Conditions : Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Blasts 0.1 Percent or More of Bone Marrow Nucleated Cells; Blasts 5 Percent or More of Bone Marrow Nucleated Cells; Recurrent Acute Myeloid Leukemia; Recurrent High Risk Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia Interventions : Drug: Azacitidine; Drug: Cytarabine; Drug: Fludarabine Phosphate; Drug: Methotrexate; Drug: Pevonedistat; Drug: Therapeutic Hydrocortisone Sponsor : National Cancer Institute (NCI) Not yet recruiting. 01/23/2019 08:45
Conditions : Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute; Renal Insufficiency; Hepatic Impairment Interventions : Drug: Azacitidine; Drug: Pevonedistat Sponsor : Millennium Pharmaceuticals, Inc. Not yet recruiting.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications